Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa

We thank Yoshioka, Yoshida, and Yoshikawa (1) for their interest and comments on our article (2) on the use of a short course of intensive insulin therapy in newly diagnosed type 2 diabetic patients. We are pleased that they think this strategy has merit. Our study was an initial pilot study and did not include detailed measures of insulin sensitivity, and we acknowledge this in the article. Yoshioka, Yoshida, and Yoshikawa make the point that insulin secretion increased equally …